Weight Loss Drugs Have One Big Issue; These Companies Want to Fix It
The good news for the obese population in the USA: FDA is considering allowing the combination version of eli lilly and co (LLY.US) weight loss drug.
(FDA) agreed on Friday to reconsider the decision made last month, which banned private drug compounders from selling their own compounded versions of eli lilly and co's weight loss and diabetes treatment drugs.
Top Gap Ups and Downs on Friday: TSLA, NVO, WFC and More
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say
European Equities Traded in the US as American Depositary Receipts Ends Week Higher in Friday Trading
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
